Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a trial designed to expand the label of the recently approved drug failed.

The world is facing a set of intertwined challenges: climate crisis, debt, food insecurity, pandemics, and fragility; and a need to accelerate access to clean air, water, and energy. Time is of the ...